We are live on
!
Find out more
Rokos Capital Management (UK) Portfolio holdings
AUM
$26.8B
Turnover
63.33%
1-Year Est. Return
90.85%
This Fund
S&P 500
This Quarter
Est. Return
+5.38%
1 Year Est. Return
+90.85%
3 Year Est. Return
+227.35%
5 Year Est. Return
+202.98%
10 Year Est. Return
–
AUM
$1.35B
AUM Growth
-$930M
(-41%)
Cap. Flow
+$153M
Cap. Flow
% of AUM
11.29%
Top 10 Holdings %
Top 10 Hldgs %
63.57%
Holding
88
New
29
Increased
13
Reduced
6
Closed
30
Avg Time Held Equity + Options
0.4
years
Top 10 Avg Time Held Equity + Options
0.3
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.5
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$144M |
| 2 |
Arrowhead Research
ARWR
|
+$40.1M |
| 3 |
Elanco Animal Health
ELAN
|
+$25.3M |
| 4 |
Marvell Technology
MRVL
|
+$23M |
| 5 |
Royalty Pharma
RPRX
|
+$22.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$146M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$40.8M |
| 3 |
Microsoft
MSFT
|
+$19.8M |
| 4 |
Zoetis
ZTS
|
+$18.1M |
| 5 |
New Fortress Energy
NFE
|
+$16.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.16% |
| 2 | Technology | 23.44% |
| 3 | Healthcare | 19.67% |
| 4 | Communication Services | 13.29% |
| 5 | Energy | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Alphabet (Google) Class C
GOOG
$4.19T
| $173M | 12.83% |
1,684,892
+1,492,752
| +777% | +$144M |
2022 Q1
4 quarters
|
|
|
2
Microsoft
MSFT
$3.99T
| $159M | 11.74% |
559,079
-77,454
| -12% | -$19.8M |
2022 Q1
4 quarters
|
|
3
State Street Energy Select Sector SPDR ETF
XLE
$43.3B
| $108M | 7.99% |
2,623,342
-40,600
| -2% | -$1.74M |
2022 Q2
3 quarters
|
|
4
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$3.36B
| $87.7M | 6.48% |
+2,000,000
| New | +$113M |
2023 Q1
0 quarters
|
|
|
5
Invesco QQQ Trust
QQQ
$483B
| $73.9M | 5.46% |
232,382
-495,225
| -68% | -$146M |
2022 Q2
3 quarters
|
|
6
EQT Corp
EQT
$33.3B
| $62.3M | 4.61% |
1,958,995
| – | – |
2022 Q2
3 quarters
|
|
|
7
Elanco Animal Health
ELAN
$11.9B
| $56.8M | 4.2% |
6,165,192
+2,145,652
| +53% | +$25.3M |
2022 Q1
4 quarters
|
|
8
Intellia Therapeutics
NTLA
$1.56B
| $51.6M | 3.82% |
1,389,296
+563,233
| +68% | +$22.1M |
2022 Q1
4 quarters
|
|
9
DELISTED
Southwestern Energy Company
SWN
| $45.7M | 3.38% |
9,105,860
| – | – |
2022 Q2
3 quarters
|
|
|
10
Arrowhead Research
ARWR
$8.08B
| $41.5M | 3.07% |
1,675,921
+1,274,999
| +318% | +$40.1M |
2022 Q3
2 quarters
|
|
11
PUT
Carnival Corporation Ltd
CCL
$36.1B
| $41M | 3.03% |
+4,000,000
| New | +$41.4M |
2023 Q1
0 quarters
|
|
|
12
Royalty Pharma
RPRX
$26.7B
| $40.1M | 2.96% |
1,106,813
+614,585
| +125% | +$22.8M |
2022 Q2
3 quarters
|
|
13
PUT
KB Home
KBH
$2.7B
| $39.8M | 2.95% |
+1,000,000
| New | +$36.5M |
2023 Q1
0 quarters
|
|
14
DELISTED
Splunk Inc
SPLK
| $36.2M | 2.68% |
382,512
+107,975
| +39% | +$10.4M |
2022 Q1
4 quarters
|
|
|
EQRX
15
DELISTED
EQRx, Inc. Common Stock
EQRX
| $29M | 2.14% |
15,342,566
+2,278,128
| +17% | +$5.19M |
2022 Q1
4 quarters
|
|
|
16
Marvell Technology
MRVL
$209B
| $28.9M | 2.14% |
672,495
+546,727
| +435% | +$23M |
2022 Q1
4 quarters
|
|
17
Snowflake
SNOW
$114B
| $21.6M | 1.59% |
144,400
+109,751
| +317% | +$16.1M |
2021 Q4
5 quarters
|
|
18
PayPal
PYPL
$49.3B
| $17.2M | 1.27% |
229,218
+120,918
| +112% | +$9.31M |
2021 Q4
5 quarters
|
|
19
Advanced Micro Devices
AMD
$887B
| $15.2M | 1.13% |
+157,495
| New | +$12.8M |
2023 Q1
0 quarters
|
|
20
Sanofi
SNY
$96.7B
| $14.8M | 1.09% |
+271,753
| New | +$13.2M |
2023 Q1
0 quarters
|
|
21
CALL
American Airlines Group
AAL
$8.2B
| $14.6M | 1.08% |
+1,000,000
| New | +$15.6M |
2023 Q1
0 quarters
|
|
22
Atlassian
TEAM
$53.7B
| $14.4M | 1.06% |
84,804
+60,248
| +245% | +$9.61M |
2022 Q4
1 quarter
|
|
23
Caribou Biosciences
CRBU
$49.4M
| $14.1M | 1.04% |
2,748,139
| – | – |
2021 Q3
6 quarters
|
|
24
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.21B
| $12.1M | 0.89% |
268,943
+152,000
| +130% | +$6.54M |
2022 Q4
1 quarter
|
|
25
lululemon athletica
LULU
$11.5B
| $11.6M | 0.86% |
+32,327
| New | +$10.1M |
2023 Q1
0 quarters
|
|
Similar funds
Rokos Capital Management (UK)'s Q1 2023 Portfolio in Review
As of Q1 2023, Rokos Capital Management (UK) held 88 positions worth $1.35B, down 41% from $2.28B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Rokos Capital Management (UK) deployed $153M of net new capital in Q1 2023, opening 29 new positions and adding to 13 existing holdings. Its largest new stake was Sanofi: 271,753 shares worth $14.8M.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 72% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $146M trimmed.
- Rokos Capital Management (UK)'s largest Q1 2023 buy was Sanofi: 271,753 shares worth $14.8M.
- Rokos Capital Management (UK) added most to Alphabet (Google) Class C in Q1 2023, an estimated $144M increase.
- Rokos Capital Management (UK)'s biggest Q1 2023 reduction was Invesco QQQ Trust, cutting an estimated $146M.
- Rokos Capital Management (UK) fully exited State Street Financial Select Sector SPDR ETF in Q1 2023, selling an estimated $40.8M.
- Rokos Capital Management (UK)'s ten largest holdings make up 64% of its $1.35B portfolio in Q1 2023.
- Rokos Capital Management (UK) opened 29 new positions and closed 30 in Q1 2023.
- Rokos Capital Management (UK)'s portfolio value fell 41% quarter-over-quarter to $1.35B.
Based on Rokos Capital Management (UK)'s 13F filing for Q1 2023, filed 15 May 2023.